Til behandling af metastatisk kræft i tyktarm/ endetarm er Xeloda, anvendt alene, blevet sammenlignet med en kombination af 5- FU og folinsyre i to undersøgelser med 1 207 patienter.
In metastatic colorectal cancer, Xeloda taken on its own has been compared with the combination of 5-FU and folinic acid in two studies involving 1,207 patients.